Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Papamichail · SciRah

Researcher profile · Semantic Scholar

K. Papamichail

Share profile

K. Papamichail — researcher profile on SciRah

h-index: 6
Works: 64
Citations: 543

Most-cited papers

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
H. Gordon, Silvia Minozzi, U. Kopylov, B. Verstockt +42 more
2024Journal of Crohn's & Colitis322 citations Open access
Semantic Scholar
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.
M. Adamina, Silvia Minozzi, J. Warusavitarne, C. Buskens +42 more
2024Journal of Crohn's & Colitis134 citations Open access
Semantic Scholar
COMBINATION THERAPY WITH IMMUNOMODULATORS IMPROVES THE PHARMACOKINETICS OF INFLIXIMAB BUT NOT VEDOLIZUMAB OR USTEKINUMAB.
A. Yarur, Dermot T. McGovern, M. Abreu, A. Cheifetz +7 more
2022Clinical Gastroenterology and Hepatology29 citations Open access
Semantic Scholar
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission
A. Yarur, M. Abreu, Parakkal Deepak, P. Beniwal-Patel +10 more
2023American Journal of Gastroenterology24 citations Open access
Semantic Scholar
Effects of intraoperative higher versus lower positive end-expiratory pressure during one-lung ventilation for thoracic surgery on postoperative pulmonary complications (PROTHOR): a multicentre, international, randomised, controlled, phase 3 trial.
Jeroen Abbenhuis, A. Abdulmomen, Asead Abdyli, M. A. Abu Elyazed +242 more
2025The Lancet Respiratory Medicine22 citations Open access
Semantic Scholar
Major Lung Resections Using Manual Suturing Versus Staplers During Fiscal Crisis.
K. Potaris, E. Kapetanakis, K. Papamichail, Elena Midvighi +9 more
2015International surgery8 citations
Semantic Scholar
Tu1830 – Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients with Inflammatory Bowel Disease
W. Clarke, K. Papamichail, N. V. Casteele, Katharine A. Germansky +5 more
2019Gastroenterology3 citations Open access
Semantic Scholar
697 Analytical and Clinical Validation of a Rapid Point-of-Care Assay for Infliximab Quantification in Patients With Ulcerative Colitis
T. van Stappen, L. Bollen, N. V. Casteele, K. Papamichail +9 more
20162 citations
Semantic Scholar
Analytical and clinical validation of a rapid point-of-care assay for infliximab quantification in patients with ulcerative colitis
T. van Stappen, L. Bollen, N. V. Casteele, K. Papamichail +9 more
20162 citations
Semantic Scholar
Su1394 Prediction of Sustained Remission After Discontinuation of Infliximab in Patients With Crohn's Disease
K. Papamichail, N. V. Casteele, S. Hauenstein, F. Princen +6 more
20142 citations Open access
Semantic Scholar
S1611 Assessing Trial Eligibility and Real-World Response to Vedolizumab in Patients With Ulcerative Colitis
Tasnim Ahmed, Aditya Mithal, Stephen Adam Le Breton, J. Huh +2 more
2025American Journal of Gastroenterology1 citations
Semantic Scholar
P793 Infliximab and prevention of colectomy in acute severe ulcerative colitis: an individual patient data meta-analysis
Z. Wang, W. Afif, J. Hanžel, T. Kobayashi +5 more
2023Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases.
K. Papamichail, M. Dubinsky, A. Cheifetz
2021Journal of the American Medical Association (JAMA)1 citations
Semantic Scholar
Sa1707 - Patients with Resolved HBV Infection (Anti-Hbc+, Hbsag-) on Anti-TNF Therapy have a Low Rate of Reactivation
W. Clarke, Shreya Amin, K. Papamichail, J. Feuerstein +1 more
20181 citations
Semantic Scholar
Long-Term Outcomes of Proactive Versus Reactive Therapeutic Drug Monitoring for Optimizing Infliximab Therapy in Inflammatory Bowel Disease
K. Papamichail, Karen A. Chachu, Ravy K. Vajravelu, Byron P. Vaughn +3 more
20171 citations
Semantic Scholar
Infliximab Concentration Thresholds During Maintenance Therapy Vary Based on the Therapeutic Outcome of Interest in Inflammatory Bowel Disease
Shana T. Rakowsky, K. Papamichail, A. Cheifetz
20171 citations
Semantic Scholar
Attitude and Barriers Towards the Implementation of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease Clinical Practice
Laurie B. Grossberg, K. Papamichail, J. Feuerstein, A. Cheifetz
20171 citations
Semantic Scholar
Sa1956 Post-Induction Adalimumab Concentration Threshold Is Associated With Short-Term Mucosal Healing in Patients With Ulcerative Colitis
K. Papamichail, F. Baert, A. Gils, S. Tops +4 more
20161 citations
Semantic Scholar
W1301 Sensitivity and Specificity of a Rapid Fecal Calprotectin Test in Patients with Chronic Non Bloody Diarrhea
G. Mantzaris, A. Roussos, A. Christidou, S. Koilakou +1 more
20081 citations
Semantic Scholar
PRECISION-GUIDED DOSING OF INFLIXIMAB IN IBD: INSIGHTS FROM THE BAYESIAN ESTIMATE SUSTAINING TROUGH (BEST) STUDY
T. Deyhim, Patricia Aragon Han, K. Papamichail, Timothy Ritter +3 more
2026Inflammatory Bowel Diseases0 citations
Semantic Scholar
S1627 Proactive Compared to Reactive Therapeutic Drug Monitoring Is Associated With Less Treatment Failure in Patients with Inflammatory Bowel Disease Treated With Adalimumab
A. Gade, Alessandra Saraga, T. Deyhim, G. Geeganage +5 more
2025American Journal of Gastroenterology0 citations
Semantic Scholar
Mo1961: POSTPARTUM DEPRESSION IS COMMON IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND IS ASSOCIATED WITH POSTPARTUM HEMORRHAGE AND PRIOR MENTAL HEALTH DISORDERS
Jessica D. Lee, Amelia Hern, N. Lue, G. Geeganage +7 more
2025Gastroenterology0 citations
Semantic Scholar
S1957 Long-Term Outcome of Patients With Inflammatory Bowel Disease and Immunogenicity to Adalimumab
Alessandra Saraga, A. Gade, T. Deyhim, G. Geeganage +5 more
2025American Journal of Gastroenterology0 citations
Semantic Scholar
Tu1879: IMPACT OF PRECISION GUIDED DOSING, FORECASTED TROUGH INFLIXIMAB CONCENTRATIONS AND CLEARANCE ON TREATMENT DECISION AND OUTCOME IN INFLAMMATORY BOWEL DISEASE: INTERIM ANALYSIS OF THE BEST STUDY
A. Cheifetz, T. Deyhim, K. Papamichail, Timothy Ritter +4 more
2025Gastroenterology0 citations
Semantic Scholar
S1758 Lower Drug Clearance Is Related to Proactive Therapeutic Drug Monitoring and Is Associated With Endoscopic Remission in Patients With Inflammatory Bowel Disease Treated With Adalimumab
T. Deyhim, Alessandra Saraga, A. Gade, G. Geeganage +6 more
2025American Journal of Gastroenterology0 citations
Semantic Scholar
Mo1840: PREGNANT INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE ARE AT INCREASED RISK FOR HEPATOBILIARY COMPLICATIONS
Jessica D. Lee, K. Papamichail, A. Cheifetz, L. Rabinowitz
2025Gastroenterology0 citations
Semantic Scholar
Tu1872: DEVELOPMENT OF A PERSONALIZED INFLIXIMAB DOSING ALGORITHM FOR ACUTE SEVERE ULCERATIVE COLITIS: RESULTS OF A MULTICENTER PHARMACOMETRICS ANALYSIS
E. Niyigena, Y. Hoffert, L. Peyrin-Biroulet, W. Afif +10 more
2025Gastroenterology0 citations
Semantic Scholar
ARTIFICIAL INTELLIGENCE DETECTION OF ENDOSCOPIC MODERATE TO SEVERE ULCERATIVE COLITIS: A NOVEL TOOL TO ENHANCE CLINICAL TRIAL RECRUITMENT
G. Geeganage, Aditya Mithal, T. Deyhim, Andy Silva-Santisteban +6 more
2025Gastrointestinal Endoscopy0 citations
Semantic Scholar
Tu1880: ASSOCIATION OF SUBCUTANEOUS INFLIXIMAB CT-P13 SERUM CONCENTRATIONS AND THERAPEUTIC OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE INTERNATIONAL MULTICENTRE STUDY
Andrea Centritto, A. Outtier, Marc Ferrante, Ž. Šubic +6 more
2025Gastroenterology0 citations
Semantic Scholar
1118: A RANDOMIZED CONTROLLED TRIAL OF HIGH-DEFINITION WHITE LIGHT ENDOSCOPY AND DYE SPRAY CHROMOENDOSCOPY FOR DYSPLASIA DETECTION IN SURVEILLANCE COLONOSCOPY OF INFLAMMATORY BOWEL DISEASE
Mohammed El-Dallal, L. Rabinowitz, G. Geeganage, B. Najam +10 more
2025Gastroenterology0 citations
Semantic Scholar
Factors associated with the development of anti-drug antibodies to tumor necrosis factor-alpha inhibitors in patients with inflammatory bowel disease.
Ming-Li Chen, T. Nopsopon, K. Papamichail, K. Costenbader +1 more
2025Minerva gastroenterologica0 citations
Semantic Scholar
Mo1934: LOW-DOSE ASPIRIN IS UNDER-PRESCRIBED IN PREGNANT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND REFLECTS DIAGNOSTIC GAPS IN PREECLAMPSIA PREVENTION FOR A HIGH-RISK POPULATION
Jessica D. Lee, Amelia Hern, N. Lue, K. Papamichail +4 more
2025Gastroenterology0 citations
Semantic Scholar
Su1803 HIGHER MAINTENANCE ADALIMUMAB CONCENTRATION IS ASSOCIATED WITH COMPLETE FISTULA HEALING IN PATIENTS WITH PERIANAL FISTULIZING CROHN'S DISEASE
K. Papamichail, Andrea Centritto, L. Guillo, Jessica Hier +20 more
2024Gastroenterology0 citations
Semantic Scholar
Mo1858 PROACTIVE COMPARED TO REACTIVE THERAPEUTIC DRUG MONITORING FOR OPTIMIZING VEDOLIZUMAB MAINTENANCE THERAPY IS ASSOCIATED WITH LESS TREATMENT FAILURE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Rachel Porth, T. Deyhim, Samantha Zullow, L. Rabinowitz +3 more
2024Gastroenterology0 citations
Semantic Scholar
1141 IBS/IBD OVERLAP: IS IT LESS COMMON THAN WE THINK?
Shana T. Rakowsky, Lauren K. Burdine, Laurie B. Grossberg, L. Rabinowitz +3 more
2023Gastroenterology0 citations
Semantic Scholar
Tu1759 INFLIXIMAB AND PREVENTION OF COLECTOMY IN ACUTE SEVERE ULCERATIVE COLITIS: AN INDIVIDUAL PATIENT DATA META-ANALYSIS
Zhi-Gang Wang, W. Afif, J. Hanžel, Taku Kobayashi +5 more
2023Gastroenterology0 citations
Semantic Scholar
680 A LARGE MULTICENTER STUDY ASSESSING FACTORS CAUSING DELAYS IN INITIATING BIOLOGIC OR NOVEL SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
A. Abadir, K. Papamichail, Angela Troia, Hyder Said +13 more
2023Gastroenterology0 citations
Semantic Scholar
Mo1719 DIETARY BELIEFS AND HABITS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Benjamin D. Mecsas-Faxon, Kajali Mishra, K. Papamichail, L. Rabinowitz +4 more
2023Gastroenterology0 citations
Semantic Scholar
Tu1755 HIGHER MAINTENANCE INFLIXIMAB CONCENTRATION IS ASSOCIATED WITH FAVORABLE THERAPEUTIC OUTCOMES IN PATIENTS WITH PERIANAL FISTULIZING CROHN'S DISEASE
K. Papamichail, L. Guillo, Jessica Hier, N. Kamperidis +12 more
2023Gastroenterology0 citations
Semantic Scholar
S767 Hospitalization and Surgery Rates in Patients Awaiting Approval of Biologics or Small Molecules for Treating Inflammatory Bowel Disease (IBD)
A. Parker, Brandon Brousse, Benjamin C. Billingsley, Alexander Carlyle +6 more
2022American Journal of Gastroenterology0 citations
Semantic Scholar
S750 Patients With High Visceral Adipose Tissue Burden Have a Higher Target Therapeutic Infliximab Concentrations: Should We Be Filling the VAT?
Shaina Sekhri, Parakkal Deepak, M. Abreu, A. Cheifetz +6 more
2022American Journal of Gastroenterology0 citations
Semantic Scholar
Mo1526: HIGHER POST-INDUCTION INFLIXIMAB CONCENTRATIONS ARE ASSOCIATED WITH FAVORABLE CLINICAL OUTCOMES IN PEDIATRIC PATIENTS WITH CROHN’S DISEASE: A POST-HOC ANALYSIS OF THE REACH STUDY
K. Papamichail, N. V. Casteele, Zhongyan Wang, M. Dubinsky +1 more
2022Gastroenterology0 citations
Semantic Scholar
236: CONCENTRATIONS OF 6-THIOGUANINE NUCLEOTIDE AND USE OF ORAL METHOTREXATE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES CORRELATE WITH A BETTER PHARMACOKINECTIC PROFILE OF INFLIXIMAB BUT NOT OF VEDOLIZUMAB OR USTEKINUMAB: THE RESULTS OF THE COMBO-IBD STUDY
A. Yarur, A. Bruss, P. Beniwal-Patel, K. Papamichail +5 more
2022Gastroenterology0 citations
Semantic Scholar
Sa1899 CLINICAL IMPLICATIONS OF INFLIXIMAB AND ADALIMUMAB THERAPEUTIC DRUG MONITORING BEFORE AND AFTER THE IMPLEMENTATION OF CORRECTIVE MEASURES FOR THE HOMOGENEOUS MOBILITY SHIFT ASSAY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
K. Papamichail, W. Clarke, Katharine A. Germansky, Sarah N. Flier +2 more
20200 citations
Semantic Scholar
Mo1775 A SURVEY STUDY OF GASTROENTEROLOGISTS' VIEWS ON DYSPLASIA SURVEILLANCE AND CHROMOENDOSCOPY IN IBD
Laurie B. Grossberg, F. Farraye, K. Papamichail, A. Cheifetz +1 more
20200 citations Open access
Semantic Scholar
Sa1866 LOW DRUG CONCENTRATIONS AND ANTI-DRUG ANTIBODY FORMATION TO THE PRIOR ANTI-TNF PREDISPOSES PATIENTS WITH INFLAMMATORY BOWEL DISEASE TO DEVELOP ANTI-DRUG ANTIBODIES TO THE SUBSEQUENT ANTI-TNF
A. Cheifetz, M. Abreu, Sarah N. Flier, K. Papamichail +7 more
20200 citations
Semantic Scholar
P092 COMPARISON OF INFLIXIMAB AND ADALIMUMAB CONCENTRATIONS BETWEEN THE ENZYME-LINKED IMMUNOSORBENT ASSAY AND THE HOMOGENEOUS MOBILITY SHIFT ASSAY (HMSA) IN INFLAMMATORY BOWEL DISEASE: AN UPDATE FOLLOWING IMPLEMENTATION OF CORRECTIVE MEASURES FOR THE HMSA
K. Papamichail, W. Clarke, N. VandeCasteele, Katharine A. Germansky +5 more
2020Gastroenterology0 citations
Semantic Scholar
567 – Adequate Infliximab Exposure During the Induction Phase is Associated with Early Complete Fistula Response in Patients with Fistulizing Crohn's Disease: A Post-Hoc Analysis of the Accent-2 Trial
K. Papamichail, N. V. Casteele, J. Jeyarajah, M. Osterman +1 more
2019Gastroenterology0 citations Open access
Semantic Scholar
Utilizing Therapeutic Drug Monitoring of Biological Therapy in Inflammatory Bowel Disease
K. Papamichail, A. Cheifetz, G. Melmed, P. Irving +12 more
2018American Journal of Gastroenterology0 citations
Semantic Scholar
Mo1848 - Proactive Infliximab Monitoring Following Reactive Testing is Associated with Better Clinical Outcomes than Reactive Testing Alone in Patients with Inflammatory Bowel Disease
K. Papamichail, Ravy K. Vajravelu, Byron P. Vaughn, M. Osterman +1 more
20180 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Cheifetz×36
Invite
A. Cheifetz — researcher profile on SciRah
Laurie B. Grossberg×11
Invite
Laurie B. Grossberg — researcher profile on SciRah
L. Rabinowitz×11
Invite
L. Rabinowitz — researcher profile on SciRah
N. V. Casteele×9
Invite
N. V. Casteele — researcher profile on SciRah

×9

Invite

T. Deyhim — researcher profile on SciRah

Invite

G. Melmed — researcher profile on SciRah

Invite

R. Battat — researcher profile on SciRah

Invite

M. Dubinsky — researcher profile on SciRah

J. Feuerstein×6

Invite

J. Feuerstein — researcher profile on SciRah

G. Geeganage×6

Invite

G. Geeganage — researcher profile on SciRah

Invite

A. Yarur — researcher profile on SciRah

Invite

M. Abreu — researcher profile on SciRah